9th International AIDS Society Conference on HIV Science

July 23, 2017 - 12:15am - July 26, 2017 - 11:45pm
Venue: 
Palais des Congrès, 2 Place de la Porte Maillot, Paris, France

Join us for the 9th International AIDS Society Conference on HIV Science in Paris, France. This year, we have an impressive lineup of poster presentations that showcase the inspiring and ambitious work MSH is doing to improve HIV treatment and care around the world, particularly in the Democratic Republic of the Congo, Malawi, Nigeria, and Swaziland.

Among the many topics that we will cover at the conference is MSH’s pioneering work on the prevention of mother-to-child transmission in Malawi through Option B+. Erik Schouten, MSH's Country Lead and Director of the District Health System Strengthening and Quality Improvement for Service Delivery Project in Malawi, supported the roll-out of the program and will present the preliminary results of a study of the country’s success thus far.

Q&A with Erik Schouten

MSH IAS 2017 Presentations

Strengthening the "last mile" distribution system of HIV-related commodities in two DRC provinces to improve product availability in support of the 90-90-90 goal

July 24, 2017 @ 12:30-14:30 in Poster Exhibition Area, Level 3

PMTCT program utilization and HIV transmission rates in adolescent mothers compared to adult mothers: A nationally representative sample of women screened at 4-26 weeks postpartum in Malawi

July 24, 2017 @ 12:30-14:30 in Poster Exhibition Area, Level 3

The therapeutic outcomes of TB/HIV co-infected patients in IHPplus-supported HIV care sites in the Lualaba mining province in the DRC

July 24, 2017 @ 12:30-14:30 in Poster Exhibition Area, Level 3

Maternal health and ART use at 4-26 weeks postpartum in Option B+ in Malawi

July 24, 2017 @ 12:30-14:30 in Poster Exhibition Area, Level 3

Impact of mobile technology in improving tracking outcomes in northern Nigeria

July 25, 2017 @ 12:30-14:30 in Poster Exhibition Area, Level 3

Positive Health Dignity and Prevention (PHDP) – Imperative Intervention towards the achievement of the second and third 90s of the United Nation’s 90-90-90 goal

July 25, 2017 @ 12:30-14:30 in Poster Exhibition Area, Level 3

Reasons for switching from first line to second line ART regimen among patients recorded in the RxSolution database in Swaziland

July 25, 2017 @ 12:30-14:30 in Poster Exhibition Area, Level 3

National evaluation of Option B+ in Malawi: High maternal ART coverage and low early infant transmission in all areas of the country by ART timing and geographical region

July 25, 2017 @ 12:30-14:30 in Poster Exhibition Area, Level 3

An exploratory study to determine the survival period to switching for adult ART patients (15+ years) in Swaziland using routinely collected data

July 25, 2017 @ 13:00-14:00 in Poster Discussion Session: Maillot Room

Predictors of mother-to-child transmission in women on ART: Results from a national evaluation of Malawi’s PMTCT program

July 26, 2017 @ 12:30-14:30 in Poster Exhibition Area, Level 3

Printer Friendly VersionPDF